Alabama Medical Marijuana Doctor Info

Open Now10:00am - 10:00pm
medical
medical

Hours Of Operation

  • mon10:00am - 10:00pm
  • tue10:00am - 10:00pm
  • wed10:00am - 10:00pmOpen Now
  • thurs10:00am - 10:00pm
  • fri10:00am - 10:00pm
  • sat10:00am - 10:00pm
  • sun10:00am - 10:00pm

Montgomery doctor- Alabama Medical Marijuana Doctor Info

About Us

Alabama Medical Marijuana Laws: Effective April 1st, 2014, SB 174 or “Carly’s Law,” allows the possession and use of CBD oil by individuals suffering from a debilitating epileptic condition as a defense against prosecution for unlawful possession of marijuana. On July 1st, 2016 HB 61 or “Leni’s Law,” amended Carly’s Law, allowing the possession and use of CBD oil by individuals suffering from a debilitating medical condition (see list below) by a physician with whom the patient has a bonafide doctor-patient relationship CBD oil is Cannabidiol, a cannabinoid found in Cannabis, in a form essentially free of plant material and contains a THC level of no more than 3%. As of this date, it is unclear according to Alabama State Law where patients or physicians may procure CBD oil for treatment of a debilitating medical condition. Alabama Medical Marijuana Patients: Patients with an authorized prescription for CBD or a parent or legal guardian on behalf of an authorized patient may possess and use CBD for medication due to a debilitating medical condition. A debilitating medical condition includes: -cachexia or wasting syndrome, -severe or chronic pain, seizures, -severe nausea, -severe and persistent muscle spasms, or any other condition that is both severe and resistant to conventional medicine as diagnosed and documented by a doctor with whom the patient has a bona fide doctor-patient relationship. No entity of any state agency shall begin processes to remove a child from home based solely on the child’s or parent’s possession or use of CBD as outlined in Leni’s Law. Alabama Medical Marijuana Doctors: The University of Alabama Department of Neurology shall retain sole authority for the prescription and use of CBD as a treatment. Only health care practitioners of the University of Alabama Department of Neurology may authorize the prescription of and treatment using CBD, including the use or amount of CBD used to treat a person with a debilitating epileptic condition. Under Leni’s Law, it is an affirmative defense for a patient to possess and use CBD Oil if they have a debilitating medical condition as diagnosed by a doctor with whom they have a bona fide doctor-patient relationship and the CBD is likely to provide relief from this condition. Any entity or affiliated group working under the University of Alabama Department of Neurology shall not be subject to prosecution involving unlawful possession, distribution, use or prescription of marijuana in activities directly related to Carly’s Law. The University of Alabama Department of Neurology established a research and development study dedicated to determining the medical benefits and applications of CBD for individuals facing debilitating epileptic conditions. To enroll in this study, patients should discuss with their primary neurologist and submit all necessary medical and referral paperwork as described on their website. Alabama Medical Marijuana Service Locations: Patients diagnosed with debilitating epileptic ailments by a certified neurologist may discuss using CBD oil as a treatment in the Birmingham, Montgomery, Huntsville, Mobile, Auburn, Tuscaloosa, Gulf Shores, Dothan, Gadsden, Orange Beach, Anniston, Fairhope, Cullman, Selma, Talladega, Opelika, Prattville, Troy, Phenix City, Fort Payne, Vestavia Hills, Dauphin Island, Tuskegee, Guntersville, Homewood, Wetumpka, Clanton, Eufaula, Sylacauga and Mountain Brook Areas.

Hours Of Operation

  • mon10:00am - 10:00pm
  • tue10:00am - 10:00pm
  • wed10:00am - 10:00pmOpen Now
  • thurs10:00am - 10:00pm
  • fri10:00am - 10:00pm
  • sat10:00am - 10:00pm
  • sun10:00am - 10:00pm
Address
N/A
Montgomery, AL 36117
Phone
(844) 933-3627
Email
customerservice@weedmaps.com
Member Since
2017